Patient in Science Gala "24 Stories to Raise Awareness," on July 2nd. Sign up!
20 June, 202515th Edition of the "Aragón Investiga Awards"
23 June, 2025
The SEED-ALS project, with the participation of the IIS Aragón, promotes a multidisciplinary collaboration to accelerate research on Amyotrophic Lateral Sclerosis, with the aim of improving the diagnosis and treatment of this neurodegenerative disease.
In the framework of the World Amyotrophic Lateral Sclerosis (ALS) Day, which is commemorated every 21 June, the Center for Biomedical Research Network (CIBER) highlights the launch at the beginning of the year of the SEED-ALS project (Synergizing Efforts to Develop and Accelerate Breakthroughs in ALS Research), an unprecedented national initiative that brings together leading ALS research teams in Spain.
ALS is a neurodegenerative disease that, despite its low prevalence, has a devastating impact on those affected and their families. Currently, its causes are unknown, and there are no specific tools for early diagnosis, monitoring, or effective treatment.
Given this scenario, the SEED-ALS project was created with the aim of accelerating scientific advances in this disease and improving its clinical management. The initiative has a duration of two years and has been funded with 3,9 million euros, granted by the Carlos III Health Institute.The project is coordinated by the Neurodegenerative Diseases Department of CIBER (CIBERNED).
The SEED-ALS consortium is made up of 27 research groups, distributed across 13 autonomous communities, and includes all the national (CSUR) and European (ERN EURO-NMD) reference units in ALS. It is a multidisciplinary collaboration ranging from basic to clinical research.
El Aragón Health Research Institute (IIS Aragón), which since its creation has shown a firm commitment to the study of Amyotrophic Lateral Sclerosis, is an active part of the project. Su participación It is articulated through the LAGENBIO group (TERAGEN and REGENERAGEN) of the University of Zaragoza, and of the Miguel Servet and Lozano Blesa University Hospitals, through their Neurology Services.
This strategic alliance reinforces the scientific community's commitment to advancing knowledge of ALS and developing solutions that improve patients' quality of life.
Main Image: SEED-ALS has the participation of patient associations and foundations
